Zaloguj się

Shuanghe Peng

Department of Pathology

The Second Hospital of Tianjin Medical University

BIOGRAPHY

Shuanghe Peng has not added Biography.

If you are Shuanghe Peng and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.

Clinica chimica acta; international journal of clinical chemistry Dec, 2017 | Pubmed ID: 29080691

Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis.

Oncotarget Nov, 2017 | Pubmed ID: 29254251

Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals.

Clinical and experimental medicine May, 2018 | Pubmed ID: 29362922

Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.

Clinica chimica acta; international journal of clinical chemistry May, 2018 | Pubmed ID: 29462592

Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma.

Clinica chimica acta; international journal of clinical chemistry Nov, 2018 | Pubmed ID: 30006290

Neutrophil-lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis.

Cancer management and research , 2018 | Pubmed ID: 30271208

Correction: Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis.

Oncotarget 11, 2018 | Pubmed ID: 30555638

Intra-Familial Phenotypic Heterogeneity and Telomere Abnormality in von Hippel- Lindau Disease: Implications for Personalized Surveillance Plan and Pathogenesis of VHL-Associated Tumors.

Frontiers in genetics , 2019 | Pubmed ID: 31068970

Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer.

Vaccines Jul, 2021 | Pubmed ID: 34358202

Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer.

Frontiers in genetics , 2022 | Pubmed ID: 35559045

INSTITUTIONS

The Second Hospital of Tianjin Medical University

JOVE ARTICLES

Economical and Efficient Protocol for Isolating and Culturing Bone Marrow-derived Dendritic Cells from Mice

Huiqin Tang^*,1,

Hui Xie^*,1,

Zhun Wang¹,

Shuanghe Peng²,

Wenli Ni¹,

Linpei Guo³

¹Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University,

²Department of Pathology, The Second Hospital of Tianjin Medical University,

³Department of Urology, The Affiliated Wuxi No.2 People’s Hospital of Nanjing Medical University

Immunology and Infection

Prywatność

Warunki Korzystania

Zasady

Skontaktuj Się z Nami

Poleć Bibliotece

BIULETYNY JoVE

Badania

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archiwum

Edukacja

JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Strona Wydziału

Autorzy

Przegląd
Proces Publikacji
Rada Redakcyjna
Zakres i Zasady
Recenzja ekspercka
FAQ
Prześlij

Bibliotekarze

Przegląd
Referencje
Subskrypcje
Dostęp
Zasoby
Biblioteczna Rada Doradcza
FAQ

O JoVE

Przegląd
Kierownictwo
Blog
JoVE Help Center
JoVE Sitemap

Shuanghe Peng

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Pathology

The Second Hospital of Tianjin Medical University

Economical and Efficient Protocol for Isolating and Culturing Bone Marrow-derived Dendritic Cells from Mice

Department of Pathology